obtaining data on the precision of kappa reliabil ity estimates (a statistical measure that assesses
level of agreement between raters that corrects for chance agreement due to prevalence rates)
in the context of clinical settings with high leve ls of diagnostic comorbidity. For DSM-5, field
trials were extended by using two distinctive designs: one in large, diverse medical-academic
settings, and the other in routine clinical practice s. The former capitalized on the need for large
sample sizes to test hypotheses on reliability and clinical utility of a range of diagnoses in a